Accuray Announces Regionalized Management Strategy for Americas

New Organization Drives Focus on Sales and Revenue Growth

SUNNYVALE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today
plans to establish an America's region thereby establishing regionalized
management and operational oversight worldwide across the entire company.

The formation of this new Americas region, along with the already established
regions of Europe, Asia and Japan, gives each region control of revenue and
profitability and responsibility for establishing a full range of dedicated
services, including sales, marketing and operations, to meet their regional
customers' needs. The regions will focus on driving sales and revenue,
building market share, and managing the local support functions, while Accuray
Corporate will remain focused on global strategy, governance and reporting,
and building the necessary platforms to enable efficient and effective
operations across the regions.

The newly established Americas region will include the United States, Canada
and Latin America. Michael Brandt, who previously served as the General
Manager of Accuray Europe, will assume the role of General Manager of the
Americas. Jim English, who has been in the Sales organization at Accuray since
March 2004, will be promoted to Vice President and will be responsible for all
North America sales.

"Creating teams with a regional focus encourages cooperation between
functional groups and enables us to be responsive to local market conditions,"
said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray
Incorporated. "We have seen the benefits of this approach in our international
markets and believe it can accelerate our growth in the Americas."

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.

About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global
leader in the field of radiosurgery dedicated to providing an improved quality
of life and a non-surgical treatment option for those diagnosed with cancer.
Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which
extends the benefits of radiosurgery to include extracranial tumors, including
those in the spine, lung, prostate, liver and pancreas. To date, the
CyberKnife System has been used to treat more than 70,000 patients worldwide
and currently more than 176 systems have been installed in leading hospitals
in the Americas, Europe and Asia. For more information, please visit
www.accuray.com.

Safe Harbor Statement
The foregoing may contain certain forward-looking statements that involve
risks and uncertainties, including uncertainties associated with the medical
device industry. Except for the historical information contained herein, the
matters set forth in this press release, including statements relating to
management, operational structure, and commercialization of products are
forward-looking statements within the meaning of the "safe harbor" provisions
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements speak only as of the date the statements are made and are based on
information available at the time those statements are made and/or
management's good faith belief as of that time with respect to future events.
You should not put undue reliance on any forward-looking statements. Important
factors that could cause actual performance and results to differ materially
from the forward-looking statements we make include: market acceptance of
products; competing products, the combination of our products with
complementary technology; and other risks detailed from time to time under the
heading "Risk Factors" in our report on Form 10-K for our 2009 fiscal year and
our other filings with the Securities and Exchange Commission. The Company's
actual results of operations may differ significantly from those contemplated
by such forward-looking statements as a result of these and other factors. We
assume no obligation to update forward-looking statements to reflect actual
performance or results, changes in assumptions or changes in other factors
affecting forward-looking information, except to the extent required by
applicable securities laws.

Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
Euan Thomson, Ph.D.
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869

SOURCE Accuray Incorporated

Media Contact: Stephanie Tomei, Senior Manager, Marketing Communications,
+1-408-789-4234, stomei@accuray.com, or Investor Contact: Tom Rathjen, Vice
President, Investor Relations, +1-408-789-4458, trathjen@accuray.com, both of
Accuray Incorporated